sever
acut
respiratori
syndrom
sar
pandem
reveal
zoonot
transmiss
anim
coronavirus
cov
human
pose
signific
threat
public
health
warrant
surveil
develop
countermeasur
activ
host
cell
proteas
cleav
activ
sarscov
spike
protein
essenti
viral
infect
constitut
target
intervent
howev
ident
proteas
involv
unclear
pioneer
studi
identifi
cathepsin
type
ii
transmembran
serin
proteas
cellular
activ
sarscov
demonstr
sever
emerg
virus
might
exploit
enzym
promot
spread
review
proteolyt
system
hijack
sarscov
protein
activ
discuss
contribut
viral
spread
host
outlin
antivir
strategi
target
enzym
paper
form
part
seri
invit
articl
antivir
research
sar
mer
year
research
highli
pathogen
human
coronavirus
coronavirus
envelop
singl
strand
rna
virus
caus
gastrointestin
respiratori
neurolog
symptom
sever
mammalian
speci
bird
holm
anim
coronavirus
pose
sever
threat
host
instanc
transmiss
gastroenter
viru
infect
newborn
seroneg
piglet
almost
invari
result
fatal
outcom
laud
et
al
contrast
human
coronavirus
hcov
identifi
far
usual
induc
common
coldlik
symptom
holm
wever
van
der
hoek
although
sever
diseas
develop
young
children
elderli
immunocompromis
patient
chiu
et
al
gors
et
al
jean
et
al
jevsnik
et
al
van
der
hoek
et
al
woo
et
al
virus
circul
global
frequent
display
season
mainli
studi
elabor
regul
gene
express
percept
coronaviru
infect
larg
harmless
human
prevail
sinc
discoveri
first
human
coronavirus
late
chang
dramat
outbreak
sever
respiratori
syndrom
coronaviru
sarscov
southern
china
winter
infect
novel
coronaviru
caus
sever
respiratori
diseas
sar
took
fatal
cours
roughli
infect
patient
risk
fatal
outcom
increas
age
peiri
et
al
stadler
rappuoli
viru
rapidli
spread
throughout
asia
introduc
intern
travel
countri
outbreak
final
contain
juli
patient
afflict
almost
lost
live
cheng
et
al
outbreak
sar
trace
back
bat
li
et
al
believ
natur
reservoir
sarscov
civet
cat
raccoon
dog
guan
et
al
may
serv
intermedi
host
find
reveal
first
time
zoonot
transmiss
anim
coronavirus
human
pose
seriou
threat
public
health
wang
eaton
sar
pandem
sporad
zoonot
infect
detect
except
three
laboratori
infect
suggest
threat
might
subsid
howev
recent
emerg
novel
highli
pathogen
middl
east
respiratori
syndrom
mer
cov
zaki
et
al
identif
close
relat
virus
bat
annan
et
al
demonstr
spillov
coronavirus
anim
human
occur
time
unforese
consequ
public
health
therefor
essenti
understand
virus
invad
host
caus
diseas
process
prevent
host
cell
entri
first
step
viral
life
cycl
constitut
target
treatment
prevent
coronavirus
encod
three
surfac
protein
spike
membran
envelop
e
e
protein
play
role
particl
assembl
releas
master
protein
bind
host
cell
receptor
fuse
viral
membran
cellular
membran
process
essenti
infecti
entri
healdsarg
gallagh
addit
sarscov
spike
protein
sarss
major
target
neutral
antibodi
respons
simmon
et
al
yang
et
al
consequ
viral
protein
focu
sar
research
month
discoveri
viru
shown
sarss
use
angiotensinconvert
enzym
receptor
entri
host
cell
wang
et
al
mainli
type
ii
pneumocyt
enterocyt
ham
et
al
et
al
recent
research
demonstr
sarss
interact
suffici
host
cell
entri
addit
protein
need
proteolyt
activ
host
cell
proteas
fuse
viral
target
cell
membran
cellular
local
respons
enzym
determin
cellular
compart
membran
fusion
occur
activ
host
cell
proteas
essenti
sarscov
infect
simmon
et
al
make
enzym
potenti
target
intervent
present
review
discuss
proteolyt
pathway
prime
sarss
membran
fusion
introduc
respons
proteas
outlin
antivir
strategi
target
proteas
sarscoronaviru
spike
protein
function
organ
membran
fusion
reaction
coronaviru
protein
includ
sarss
share
sever
featur
peplom
coronaviru
protein
protrud
virion
surfac
respons
coronalik
shape
virion
observ
upon
electron
microscopi
protein
contain
ntermin
signal
sequenc
synthes
constitut
secretori
pathway
infect
cell
fig
travers
secretori
pathway
toward
site
assembl
progeni
virion
endoplasmat
reticulum
golgi
apparatu
intermedi
compart
ergic
protein
trimer
extens
modifi
nglycan
belouzard
et
al
healdsarg
gallagh
function
organ
protein
resembl
sever
viral
glycoprotein
includ
influenza
hemagglutinin
human
immunodefici
viru
envelop
protein
collect
refer
class
membran
fusion
protein
harrison
hallmark
protein
presenc
ntermin
surfac
unit
term
context
cov
protein
harbor
receptor
bind
domain
ctermin
transmembran
unit
term
context
cov
protein
contain
function
element
requir
membran
fusion
fusion
peptid
heptad
repeat
transmembran
domain
fig
notabl
separ
surfac
transmembran
unit
upon
proteolyt
cleavag
host
cell
proteas
prerequisit
membran
fusion
driven
class
membran
fusion
protein
second
characterist
share
class
membran
fusion
protein
transit
transmembran
unit
thermost
proteaseinsensit
conform
term
sixhelixbundl
upon
success
complet
membran
fusion
reaction
harrison
first
indispens
step
entri
cascad
bind
protein
receptor
receptor
bind
domain
rbd
sarss
locat
cterminu
subunit
bind
high
affin
wong
et
al
structur
rbd
complex
catalyt
domain
determin
atom
level
li
li
et
al
surfac
unit
contain
ntermin
signal
peptid
target
protein
import
constitut
secretori
pathway
receptor
bind
domain
rbd
mediat
bind
transmembran
unit
harbor
function
element
requir
membran
fusion
fusion
peptid
two
heptad
repeat
also
contain
transmembran
domain
anchor
protein
within
cellular
membran
cytoplasm
tail
requir
appropri
intracellular
traffick
spike
protein
arrow
indic
amino
acid
posit
cleav
cellular
proteas
rbd
consist
two
subdomain
core
extend
loop
core
structur
conserv
sarss
cov
protein
contact
contrast
structur
extend
loop
differ
among
cov
protein
subdomain
respons
sarss
contact
li
et
al
sequenc
variat
extend
loop
determin
affin
sarss
bind
associ
potenti
sarscov
zoonot
transmiss
li
li
et
al
bind
sarss
trigger
subtl
conform
chang
within
protein
render
protein
suscept
activ
membran
fusion
discuss
upon
activ
fusion
peptid
locat
nterminu
subunit
insert
target
cell
membran
either
plasma
membran
endosom
membran
describ
stage
subunit
connect
viral
membran
via
transmembran
domain
cellular
membran
via
fusion
peptid
subsequ
nand
ctermin
heptad
repeat
within
subunit
fold
back
onto
form
sixhelixbundl
structur
consequ
subunit
collaps
viral
cellular
membran
pull
close
proxim
ultim
fuse
similar
mechan
oper
class
membran
fusion
protein
howev
differ
stimuli
activ
viral
fusion
protein
one
respons
activ
sarss
focu
remaind
review
order
mediat
membran
fusion
phindepend
virus
hiv
util
bind
cell
surfac
co
receptor
order
trigger
glycoprotein
reorgan
describ
phdepend
virus
low
ph
acidifi
endosom
organel
suffici
plemper
sarscov
entri
sensit
lysosomotrop
agent
simmon
et
al
yang
et
al
initi
suggest
requir
acid
ph
mediat
trigger
sarss
yang
et
al
similar
influenza
howev
number
factor
suggest
entri
might
straightforward
sarscov
simmon
et
al
mani
coronavirus
phindepend
entri
insensit
lysosomotrop
agent
nash
buchmeier
celltocel
fusion
occur
neutral
ph
kooi
et
al
likewis
cellcel
fusion
occur
absenc
acidif
requir
addit
trypsin
effici
fusion
condit
low
express
target
cell
simmon
et
al
similarli
block
infect
mediat
lysosomotrop
agent
could
bypass
bind
viru
cell
surfac
treat
trypsin
elastas
thermolysin
matsuyama
et
al
simmon
et
al
final
mani
phdepend
virus
includ
influenza
dengu
inactiv
prematur
exposur
low
ph
irrevers
drive
glycoprotein
conform
rearrang
postfus
state
prior
contact
target
membran
contrast
puls
sarss
pseudotyp
onto
lentivir
particl
inactiv
infect
simmon
et
al
phdepend
rhabdovirus
also
insensit
prematur
trigger
steffen
et
al
due
revers
natur
glycoprotein
backov
jardetzki
howev
sarss
structur
featur
common
class
viral
glycoprotein
hiv
influenza
hemagglutinin
ha
rhabdoviru
glycoprotein
belong
famili
class
iii
membran
fusion
protein
one
explan
discord
result
phdepend
endosom
cellular
factor
requir
sarscov
membran
fusion
rather
viru
requir
acid
trigger
influenza
ha
prime
infect
within
endosom
certain
target
cell
endosom
proteas
boycott
et
al
suggest
similar
circumst
may
occur
sarscov
inde
use
broadspectrum
follow
specif
inhibitor
demonstr
sarscov
requir
activ
endosom
cystein
proteas
like
cathepsin
l
simmon
et
al
fig
cathepsin
l
ubiquit
express
explain
human
ad
cell
line
restrict
appear
exist
effici
entri
inhibitor
entir
specif
howev
use
partial
cellfre
model
membran
fusion
demonstr
cathepsin
l
cathepsin
prime
sarscov
membran
fusion
interact
temperatur
simmon
et
al
thu
theoriz
model
engag
sarss
trigger
subtl
conform
chang
within
protein
render
protein
suscept
activ
host
cell
proteas
like
exposur
cryptic
cleavag
site
cleavag
subunit
sarss
cellular
proteas
liber
conserv
fusion
peptid
locat
directli
adjac
cleavag
site
madu
et
al
upon
protein
cleavag
fusion
peptid
insert
target
cell
membran
membran
merger
commenc
describ
precis
site
proteolysi
cathepsin
l
unclear
unlik
proteas
prime
viral
glycoprotein
furin
cathepsin
l
rel
indiscrimin
term
recognit
site
biniossek
et
al
thu
may
rather
defin
site
proteolysi
trim
multipl
cleavag
point
cathepsin
l
cleavag
site
report
close
predict
boundari
posit
sarss
bosch
et
al
howev
function
data
shown
mutagenesi
demonstr
site
inde
requir
prime
protein
infect
base
data
proteas
trypsin
elastas
although
initi
cleav
may
occur
site
belouzard
et
al
introduct
complet
furin
cleavag
site
enhanc
cellcel
fusion
folli
et
al
critic
site
proteolysi
locat
posit
closer
predict
fusion
peptid
madu
et
al
academ
interest
fact
sever
coronavirus
util
cathepsin
l
entri
gierer
et
al
hofmann
et
al
kawas
et
al
qiu
et
al
simmon
et
al
offer
opportun
rapid
develop
antivir
compound
cathepsin
long
target
pharmaceut
interest
vasiljeva
et
al
diseas
osteoporosi
cardiovascular
diseas
cancer
due
myriad
function
impact
aspect
diseas
pathogenesi
collagen
degrad
chapman
et
al
antigen
process
pietschmann
et
al
inde
sever
librari
cystein
proteas
inhibitor
sourc
compil
initi
intent
use
screen
inhibitor
close
relat
cathepsinlik
proteas
found
mani
parasit
infect
lesli
librari
prove
excel
mine
antiparasit
ang
et
al
antivir
zhou
et
al
drug
lead
compound
extens
review
elsewher
zhou
simmon
briefli
inhibitor
gener
peptid
bind
activ
site
enzym
either
revers
case
potent
tetrahydroquinolin
oxocarbaz
compound
shah
et
al
simmon
et
al
irrevers
case
dipeptidyl
epoxyketon
inhibitor
zhou
et
al
contrast
small
molecul
inhibitor
cathepsin
l
recent
identifi
screen
assay
use
sarss
bear
pseudotyp
may
specif
peptidomimet
inhibitor
cathepsin
b
activ
inhibit
adedeji
et
al
howev
entir
clear
strategi
would
adventur
therapeut
treatment
base
result
inhibitor
escap
mutant
filovirus
similar
sarscov
requir
cystein
proteas
effici
viral
entri
although
cathepsin
b
play
greater
role
cathepsin
l
ebolaviru
glycoprotein
prime
chandran
et
al
unidentifi
proteas
perform
function
filovirus
gnirss
et
al
misasi
et
al
ebolaviru
escap
mutant
rel
easili
made
resist
inhibitor
cathepsin
b
mutant
remain
sensit
broad
spectrum
cystein
proteas
inhibitor
suggest
viru
switch
proteas
usag
wong
et
al
thu
hypothes
broadli
activ
proteas
inhibitor
may
lessen
even
prevent
escap
zhou
simmon
key
stimulu
investig
whether
sarss
hijack
proteas
cathepsin
l
ensur
activ
came
novel
insight
activ
influenza
viru
host
cell
proteas
influenza
virus
like
sarscov
mainli
infect
respiratori
epithelia
depend
proteolyt
activ
entrymedi
surfac
protein
hemagglutinin
ha
acquisit
infect
bertram
et
al
et
al
basi
cell
cultur
studi
posit
ha
may
activ
sever
host
cell
proteas
secret
bind
sarscoronaviru
cellular
receptor
result
uptak
virion
endosom
spike
protein
activ
ph
depend
cystein
proteas
cathepsin
l
activ
spike
protein
cathepsin
l
block
lysosomotrop
agent
like
bafilomycin
ammonium
chlorid
indirectli
inhibit
cathepin
l
activ
interf
endosom
acidif
compound
directli
block
proteolyt
activ
cathepsin
l
like
altern
spike
protein
activ
close
cell
surfac
result
fusion
viral
membran
plasma
membran
lung
lumen
kido
et
al
mileston
studi
zhirnov
et
al
indic
might
case
activ
ha
cultur
human
adenoid
epitheli
cell
model
human
respiratori
epithelium
shown
cellassoci
process
occur
ha
biogenesi
infect
cell
viral
entri
target
cell
howev
ident
proteas
involv
remain
unclear
et
al
chaipan
et
al
dem
onstrat
member
type
ii
transmembran
serin
proteas
ttsp
famili
prime
candid
transmembran
proteas
serin
hat
human
airway
tryptas
shown
activ
influenza
viru
subtyp
previous
pandem
human
et
al
found
activ
ha
protein
influenza
viru
chaipan
et
al
recent
studi
ad
mspl
matriptas
list
ha
activ
ttsp
baron
et
al
beaulieu
et
al
hamilton
et
al
okumura
et
al
addit
evid
report
activ
human
metapneumoviru
cleavag
fusion
protein
shirogan
et
al
indic
sever
respiratori
virus
may
hijack
relat
proteas
promot
spread
host
human
ttsp
famili
compris
member
express
respiratori
tract
report
antali
et
al
protein
exhibit
modular
organ
fig
nterminu
locat
cytoplasm
interact
compon
cytoskeleton
signal
molecul
follow
transmembran
domain
insert
protein
plasma
membran
extracellular
portion
compris
ntermin
stem
domain
built
combin
structur
domain
ctermin
trypsinlik
proteas
domain
antali
et
al
stem
region
regulatori
function
includ
modul
enzymat
activ
substrat
specif
mediat
proteinprotein
interact
ctermin
proteas
domain
contain
catalyt
triad
consist
serin
histidin
aspart
recogn
cleav
substrat
includ
hormon
growth
differenti
factor
viral
surfac
protein
antali
et
al
ttsp
synthes
inact
proenzym
zymogen
activ
upon
proteolyt
cleavag
prodomain
catalyt
domain
matur
protein
domain
remain
coval
associ
via
disulfid
bond
fig
shed
enzymat
activ
ectodomain
report
antali
et
al
although
physiolog
role
instanc
larg
unknown
well
establish
ttsp
regul
divers
biolog
process
includ
develop
homeostasi
dysregul
ttsp
express
intim
associ
variou
cancer
antali
et
al
thu
ttsp
play
import
role
health
diseas
constantli
grow
bodi
evid
suggest
virus
exploit
enzym
promot
spread
host
import
role
ttsp
sarscov
infect
first
report
three
studi
examin
impact
sarss
activ
show
express
target
cell
result
cleavag
activ
sarss
cellcel
viruscel
fusion
matsuyama
et
al
shulla
et
al
activ
render
sarssdriven
viruscel
fusion
independ
cathepsin
activ
matsuyama
et
al
shulla
et
al
increas
suscept
inhibit
peptid
target
fusion
apparatu
subunit
matsuyama
et
al
consequ
one
must
assum
sarss
activ
occur
close
cell
surfac
howev
detail
inform
cellular
local
sarss
activ
reaction
avail
present
abil
activ
sarss
seem
depend
spatial
orient
two
protein
rel
express
target
cell
activ
sarss
adjac
effector
cell
coexpress
sarss
cell
activ
protein
matsuyama
et
al
nevertheless
sarss
cleavag
detect
upon
coexpress
cell
result
shed
sarss
ectodomain
extracellular
space
function
antibodi
decoy
therefor
might
impact
sarscov
spread
least
two
way
activ
sarss
membran
fusion
could
promot
viral
spread
releas
solubl
sarss
could
compromis
viral
control
humor
immun
respons
latter
process
far
demonstr
transfect
cell
remain
investig
whether
oper
infect
host
contribut
ttsp
sarscov
infect
limit
sinc
relat
proteas
hat
also
activ
sarss
howev
sever
import
differ
sarss
activ
hat
note
sarss
residu
essenti
sarss
cleavag
trypsin
kam
et
al
also
requir
sarss
process
hat
although
formal
proof
indispens
hatmedi
sarss
activ
current
lack
result
indic
protein
differenti
recogn
hat
whether
differenti
recognit
due
differ
proteas
domain
remaind
protein
current
unknown
regardless
determin
control
cleavag
specif
clear
differenti
process
sarss
hat
import
consequ
sarss
activ
one
hat
activ
coexpress
protein
cellcel
fusion
might
contribut
syncytia
format
infect
tissu
convers
hat
express
viral
target
cell
activ
sarss
cathepsinindepend
viruscel
fusion
differ
express
level
cellular
local
et
al
proteas
could
partial
account
find
howev
like
differenti
sarss
proteolyt
process
hat
result
differenti
sarss
activ
address
question
requir
identif
far
elus
cleavag
site
sarss
final
noteworthi
activ
sarss
cellcel
viruscel
fusion
although
sarss
cleavag
detect
conceiv
ineffici
thu
undetect
cleavag
sarss
still
suffici
promot
cellcel
fusion
involv
interact
larg
cellular
surfac
usual
harbor
high
copi
number
protein
proteas
respect
whether
ineffici
sarss
process
occur
upon
engin
express
account
protein
activ
remain
determin
activ
sarscov
ttsp
infect
host
requir
express
protein
viral
target
cell
analysi
lung
tissu
uninfect
cynomolgu
macaqu
reveal
promin
express
type
pneumocyt
express
detect
type
ii
pneumocyt
although
low
level
matsuyama
et
al
within
sever
lesion
lung
sarscov
infect
anim
obviou
correl
presenc
sarscov
antigen
seen
detect
cytoplasm
enlarg
type
ii
pneumocyt
matsuyama
et
al
analysi
human
tissu
far
limit
materi
patient
infect
sarscov
immunohistochemistri
reveal
coexpress
alveolar
macrophag
type
ii
pneumocyt
comprehens
studi
detect
extens
coexpress
hat
epithelia
aerodigest
tract
although
except
note
includ
epithelia
trachea
vocal
fold
epiglotti
thu
hat
present
major
viral
target
cell
could
promot
viral
spread
infect
human
evid
ttsp
express
respiratori
epithelium
inde
respons
sarscov
activ
tissu
studi
cultur
primari
human
respiratori
epithelium
address
question
need
interest
inform
obtain
lung
adenocarcinoma
cell
line
alreadi
avail
sarscov
infect
cell
express
endogen
et
al
larg
depend
proteas
determin
inhibitor
studi
full
inhibit
infect
achiev
upon
simultan
blockad
cathepsin
l
kawas
et
al
similar
result
recent
report
infect
merscov
infect
colorect
adenocarcinoma
cell
line
endogen
express
bertram
et
al
collect
result
hint
toward
import
contribut
lesser
degre
cathepsin
l
activ
sarscov
merscov
potenti
human
coronavirus
infect
human
host
evid
import
role
infect
sarscov
human
respiratori
virus
come
anim
model
knockout
mice
kim
et
al
display
obviou
phenotyp
absenc
infect
ideal
tool
endeavor
constantli
increas
evid
point
toward
activ
sarscov
might
also
immedi
therapeut
implic
small
molecul
serin
proteas
inhibitor
camostat
mesyl
effici
inhibit
sarscov
activ
kawas
et
al
camostat
mesyl
alreadi
shown
inhibit
replic
influenza
parainfluenza
virus
prevent
develop
pneumonia
viral
myocard
infect
mice
zhirnov
et
al
addit
compound
slow
inhibit
chronic
pancreat
anim
model
jia
et
al
use
japan
treatment
human
patient
condit
thu
camostat
mesyl
could
also
employ
treatment
patient
infect
sarscov
merscov
discuss
addit
develop
novel
synthet
inhibitor
suppress
influenza
viru
spread
recent
report
treatment
sarscov
influenza
viru
infect
patient
compound
unlik
complet
abrog
viral
spread
sinc
altern
rout
activ
avail
discuss
howev
even
modest
reduct
viral
amplif
expect
base
cell
cultur
find
detail
might
well
translat
therapeut
benefit
may
tip
balanc
toward
control
viral
replic
gener
accept
cathepsin
l
ttsp
major
activ
sarss
howev
studi
sarssdriven
cellcel
fusion
indic
might
one
fusion
effector
cell
express
sarss
target
cell
endogen
express
low
amount
ineffici
rescu
either
engin
express
high
level
trypsin
treatment
simmon
et
al
observ
rais
question
whether
sarssdriven
fusion
target
cell
absenc
exogen
trypsin
depend
sarss
activ
far
uncharacter
cellular
proteas
inde
leupeptin
proteas
inhibitor
includ
cathepsin
bl
inhibitor
reduc
fusion
sarss
express
effector
cell
unmodifi
target
cell
endogen
express
sarssactiv
ttsp
detect
cell
therefor
discuss
result
suggest
far
unidentifi
leupeptinsensit
proteas
activ
sarss
cellcel
fusion
natur
proteas
potenti
contribut
sarss
activ
cellular
system
infect
host
remain
determin
studi
discuss
unambigu
demonstr
proteolyt
cleavag
sarss
essenti
infecti
entri
sarscov
addit
layer
complex
ad
sarssproteas
theme
observ
indic
sarss
also
receptor
proteolyt
process
known
shed
extracellular
space
upon
cleavag
sheddas
shed
induc
treatment
cell
pma
agent
jia
et
al
lambert
et
al
fig
haga
et
al
demonstr
bind
sarss
also
induc
shed
provid
evid
shed
import
uptak
sarscov
target
cell
furthermor
demonstr
inhibitor
display
modest
antivir
activ
sarscov
infect
mice
haga
et
al
reduc
cellular
level
note
sarscov
infect
cell
cultur
glowacka
et
al
haga
et
al
anim
rockx
et
al
human
oudit
et
al
might
account
sarssinduc
shed
notabl
express
protect
mice
experiment
induc
lung
injuri
kuba
et
al
therefor
sarssinduc
shed
might
promot
viral
uptak
might
also
contribut
sar
pathogenesi
fig
although
note
contribut
shed
viral
uptak
controversi
glowacka
et
al
interestingli
cleavag
limit
shulla
colleagu
demonstr
hat
cleav
coexpress
cleavag
associ
increas
infect
shulla
et
al
augment
sarssdriven
viruscel
entri
upon
ttsp
express
confirm
studi
howev
formal
proof
proteolysi
respons
increas
viral
infect
miss
addit
mechanist
connect
cleavag
increas
infect
well
potenti
contribut
process
cathepsinindepend
sarss
activ
unclear
similarli
unknown
cleavag
ttsp
result
shed
induc
sarss
futur
studi
need
shed
light
interest
question
novel
coronaviru
mer
emerg
jordan
septemb
laboratori
confirm
infect
death
report
worldhealthorgan
strategi
treatment
prevent
merscov
infect
urgent
requir
rais
question
whether
blockad
proteolyt
system
respons
sarss
activ
could
also
inhibit
merscov
infect
inde
initi
studi
demonstr
merssdriven
infect
certain
cell
line
depend
activ
cathepsin
bl
depend
rescu
engin
express
found
cleav
merss
protein
addit
merssdriven
infect
cell
larg
depend
activ
endogen
although
addit
blockad
cathepsin
bl
requir
full
inhibit
viral
entri
observ
suggest
sarscov
merscov
hijack
proteolyt
system
accomplish
activ
thu
share
achil
heel
suscept
therapeut
inhibit
howev
studi
requir
assess
whether
merscov
activ
cathepsin
bl
respiratori
epithelium
viru
also
hijack
activ
particular
member
ttsp
famili
promot
spread
contrast
sarscov
merscov
might
offer
second
target
attack
proteas
inhibitor
target
viral
enzym
merss
sarss
effici
cleav
unidentifi
proteas
upon
ectop
express
cell
line
thu
interest
examin
merss
also
cleav
merscov
infect
cell
cleavag
import
viral
infect
proteas
respons
potenti
target
intervent
although
combin
inhibitor
target
least
two
protein
activ
proteas
might
requir
achiev
pronounc
antivir
effect
concept
influenza
respiratori
virus
hijack
mani
function
redund
proteolyt
system
activ
host
need
reconsid
new
studi
provid
intrigu
evid
influenza
virus
human
metapneumoviru
sever
coronavirus
includ
emerg
agent
sarscov
merscov
might
hijack
activ
host
whether
virus
also
employ
ttsp
requir
investig
sarscov
merscov
also
employ
cathepsin
bl
activ
contribut
proteas
infecti
entri
key
target
cell
might
minor
confirm
import
role
proteas
viral
spread
host
requir
cathepsin
bl
knockout
mice
employ
studi
kim
et
al
reinheckel
fig
role
proteas
sarscoronaviru
entri
lung
pathogenesi
dipeptidyl
peptidas
ace
convert
angiotensin
promot
sever
lung
injuri
thu
develop
sar
via
receptor
bind
convers
protect
lung
injuri
bind
sarscoronaviru
spike
protein
induc
shed
associ
increas
cellular
uptak
sarscoronaviru
particl
activ
known
regul
via
intracellular
calcium
level
phorbol
ester
like
pma
induc
phosphoryl
cytoplasm
tail
via
pkc
activ
addit
calmodulin
known
associ
cytoplasm
tail
may
regul
shed
via
pkcdepend
activ
also
cleav
propos
cleavag
increas
sarscoronaviru
entri
whether
cleavag
result
shed
remain
investig
figur
partial
adapt
imai
et
al
cell
mol
life
sci
recent
find
cathepsin
bl
activ
essenti
ebolaviru
infect
cell
line
chandran
et
al
dispens
viral
spread
pathogenesi
mice
marzi
et
al
highlight
need
studi
final
proteas
inhibitor
camostat
mesyl
activ
use
treat
human
avail
could
employ
first
line
defens
threat
impos
emerg
respiratori
virus
